Expression of PRAD1/cyclin D1 in plasma cell malignancy: Incidence and prognostic aspects

British Journal of Haematology

Volumn 104, Issue 3, 1999, Pages 614-617

  Sonoki, Takashi ^a,b   Hata, Hiroyuki ^a   Kuribayashi, Noriomi ^a   Yoshida, Minoru ^a   Harada, Naoko ^a   Nagasaki, Akitoshi ^a   Kimura, Tatsuya ^a   Matsuno, Fumihiko ^a   Mitsuya, Hiroaki ^a   Matsuzaki, Hiromitsu ^a  

^a KUMAMOTO UNIV SCHOOL OF MEDICINE   (Japan)

^b ROYAL MARSDEN HOSPITAL   (United Kingdom)

Author keywords

Multiple myeloma; Plasma cell leukaemia; PRAD1 cyclin D1; T(11; 14)(q13; q32)

Indexed keywords

CYCLIN D1;

ADULT; AGED; ANTIGEN EXPRESSION; ARTICLE; CANCER SURVIVAL; CLINICAL ARTICLE; DIAGNOSTIC VALUE; FEMALE; GENE REARRANGEMENT; HUMAN; KARYOTYPE; MALE; MULTIPLE MYELOMA; PLASMA CELL LEUKEMIA; PRIORITY JOURNAL;

EID: 0033049846     PISSN: 00071048     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2141.1999.01204.x     Document Type: Article

References (12)

1. Bergsagel, P.L., Chesi, M., Nardini, E., Brents, L.A., Kirby, S.L. & Kuehl, W.M. (1996) Promiscuous translocations into immunoglobulin heavy chain switch regions in multiple myeloma. Proceedings of the National Academy of Sciences of the United States of America, 93, 13931-13936.
2. Chesi, M., Bergsagel, P.L., Brents, L.A., Smith, C.A., Gerhard, D.S. & Kuehl, W.M. (1996) Dysregulation of cyclin D1 by translocation into an IgH gamma switch region in two multiple myeloma cell lines. Blood, 88, 674-681.
3. Chesi, M., Nardini, E., Brents, L.A., Schrck, E., Ried, T., Kuehl, W.M. & Bergsagel, P.L. (1997) Frequent translocation t(4;14) (p16.3;q32.3) in multiple myeloma: association with increased expression and activating mutations of fibroblast growth factor receptor 3. Nature Genetics, 16, 260-264.
4. Iida, S., Rao, P.H., Butler, M., Corradini, P., Boccadoro, M., Klein, B., Chaganti, R.S.K. & Dalla-Favera, R. (1997) Deregulation of MUM1/IRF4 by chromosomal translocation in multiple myeloma. Nature Genetics, 17, 226-230.
5. Laï, J.L., Zandecki, M., Mary, J.Y., Bernardi, F., Izydorczyk, V., Flactif, M., Morel, P., Jouet, J.P., Bauters, F. & Facon, T. (1995) Improved cytogenetics in multiple myeloma: a study of 151 patients including 117 patients at diagnosis. Blood, 85, 2490-2497.
6. Motokura, T., Bloom, T., Kim, H.G., Juppner, H., Ruderman, J.V., Kronenberg, H.M. & Arnold, A. (1991) A novel cyclin encoded by a bcl1-linked candidate oncogene. Nature, 350, 512-515.
7. Nishida, K., Tamura, A., Nakazawa, N., Ueda, Y., Abe, T., Matsuda, F., Kashima, K. & Taniwaki, M. (1997) The Ig heavy chain gene is frequently involved in chromosomal translocations in multiple myeloma and plasma cell leukemia as detected by in situ hybridization. Blood, 90, 526-534.
8. Richelda, R., Ronchetti, D., Baldini, L., Cro, L., Viggiano, L., Marzella, R., Rocchi, M., Otsuki, T., Lombardi, L., Maiolo, A.T. & Neri, A. (1997) A novel chromosomal translocation t(4;14)(p16.3;q32) in multiple myeloma involves the fibroblast growth-factor receptor 3 gene. Blood, 90, 4062-4070.
9. Sawyer, J.R., Waldron, J.A., Jagannath, S. & Barlogie, B. (1995) Cytogenetic findings in 200 patients with multiple myeloma. Cancer Genetics and Cytogenetics, 82, 41-49.
10. Tricot, G., Barlogie, B., Jagannath, S., Bracy, D., Mattox, S., Vesole, D.H., Naucke, S. & Sawyer, J.R. (1995) Poor prognosis in multiple myeloma is associated only with partial or complete deletions of chromosome 13 or abnormalities involving 11q and not with other karyotype abnormalities. Blood, 86, 4250-4256.
11. Weh, H.J., Bartl, R., Seeger, D., Selbach, J., Kuse, R. & Hossfeld, D.K. (1995) Correlations between karyotype and cytologic findings in multiple myeloma. Leukemia, 9, 2119-2122.
12. Zandecki, M., Laï J.L. & Facon, T. (1996) Multiple myeloma: almost all patients are cytogenetically abnormal. British Journal of Haematology, 84, 217-227.